Cell fate acquisition and reprogramming by the proneural transcription factor ASCL1

Area of Science:

• Neuroscience
• Developmental Biology
• Cancer Biology

Background:

• ASCL1 (Achaute-like bHLH transcription factor 1) is a key proneural basic helix-loop-helix (bHLH) transcription factor.
• It plays critical roles in nervous system development, maintenance, and somatic cell reprogramming towards neuronal fates.
• Exceptions exist where ASCL1 fails to induce neurogenesis or reprogramming, and it is implicated in cancers like neuroblastoma and glioblastoma.

Purpose of the Study:

• To provide a comprehensive overview of ASCL1's diverse functions.
• To integrate foundational knowledge with recent advances in ASCL1's post-translational and transcriptional regulation.
• To offer insights into ASCL1's molecular mechanisms and therapeutic potential in development, reprogramming, and cancer.

Main Methods:

• Review of foundational studies on ASCL1's role in neuronal differentiation.
• Incorporation of recent research on ASCL1's post-translational modifications.
• Analysis of recent findings on ASCL1's transcriptional control mechanisms.

Main Results:

• ASCL1 is a potent driver of neuronal identity by reconfiguring chromatin.
• Its function is context-dependent, with some cell types refractory to reprogramming.
• ASCL1 influences non-neuronal lineages in certain developmental contexts.
• ASCL1 is a significant factor in neuroblastoma and glioblastoma pathogenesis.

Conclusions:

• A thorough understanding of ASCL1's multifaceted roles is essential for clinical applications.
• ASCL1's regulation at the post-translational and transcriptional levels dictates its diverse cellular outcomes.
• Further insights into ASCL1's molecular functions can unlock therapeutic strategies for developmental disorders and cancers.